FRIDAY, Feb. 18, 2022 (HealthDay News) — “Rogue antibodies” that seem to trigger severe blood clotting and illness in COVID-19 patients have been identified by scientists. Their analysis of blood samples from 244 patients hospitalized for COVID-19 revealed circulating antiphospholipid antibodies, which are autoantibodies that target a person’s own organsContinue Reading

FRIDAY, Jan. 28, 2022 (HealthDay News) — Two rheumatoid arthritis drugs show potential for lowering the risk of Parkinson’s disease, new research shows. Some previous studies have found that people with rheumatoid arthritis have a lower risk of Parkinson’s, and it was suggested that a class of rheumatoid arthritis drugsContinue Reading

THURSDAY, Jan. 27, 2022 (HealthDay News) — Taking vitamin D supplements may help stave off psoriasis, rheumatoid arthritis, lupus and other autoimmune diseases, a new study suggests. Previous research has hinted at this connection, but the new study is the first randomized controlled trial to look at what happens whenContinue Reading

WEDNESDAY, Jan. 26, 2022 (HealthDay News) — A one-two punch from science has clearly tagged the mononucleosis virus, Epstein-Barr, as a major cause of multiple sclerosis. The Epstein-Barr virus (EBV) appears to trigger multiple sclerosis (MS) by tricking the immune systems of some into attacking their body’s own nerve cells,Continue Reading

MONDAY, Dec 27, 2021 (HealthDay News)– When fully vaccinated cancer patients develop a breakthrough case of COVID-19, most will become seriously ill and end up hospitalized, a new study finds. The conclusion stems from the experience of 54 cancer patients who developed COVID-19. Sixty-five percent were hospitalized following infection, whileContinue Reading